Event Type: Q2 and H1 FY27 Results Conference Call and Investor/Analyst interaction

Event Date and Time: Monday, October 26, 2026 at 10:00 AM IST

Purpose: Discussion of business and financial performance for the quarter and half year ended September 30, 2026

Management Participants:

  • Dr. Ankit Thakker – Managing Director and Chief Executive Officer
  • Mr. Anand Apte – Chief Business and Strategy Officer
  • Mr. Aditya Gupta – Senior Vice President Corporate Affairs
  • Mr. Nitin Patodi – Head of Finance
  • Mrs. Suma Upparatti – Company Secretary and Compliance Officer
  • SGA – Investor Relations Advisors

Availability of Materials: The transcript and audio recordings were uploaded on the stock exchanges and company website (www.jupiterhospital.com) on October 26, 2026. The transcript states that in case of discrepancy, the audio recordings will prevail.

Financial Period Discussed: Q2 FY27 and H1 FY27 (quarter and half year ended September 30, 2026)

Key Financial Highlights:

  • Q2 FY27 Income: INR456.5 crores
  • Q2 FY27 EBITDA: INR106.9 crores
  • Q2 FY27 PAT: INR56.4 crores
  • H1 FY27 Income: INR867.5 crores
  • H1 FY27 EBITDA: INR186.2 crores
  • H1 FY27 PAT: INR93.9 crores
  • ARPOB: INR71,800
  • IP ARPOB: INR58,700
  • ALOS: 3.79 days
  • H1 Occupancy (all hospitals): 59.5%
  • H1 Occupancy (excluding Dombivli): 64.8%

Strategic and Operational Updates:

  • Board approved acquisition of leased Pune South hospital land (11,452 square meters) for INR150 crores
  • INR50 crores deposit already paid will be adjusted, limiting incremental cash outflow to INR100 crores
  • Pune South project progressing well and on schedule
  • Mira Bhayandar project in regulatory stage, expected to commence next phase before end of FY27
  • BKC project in planning stage, soon to enter regulatory clearance process
  • Dombivli hospital showed significant improvement with EBITDA impact of INR20 lakhs in Q2 versus INR9.5 crores in Q1
  • Dombivli occupancy in mid-30s%, driven by seasonally higher infectious disease burden
  • Thane hospital occupancy around 75%, potential for bed expansion subject to regulatory clearance
  • Pune hospital occupancy close to 70%, limited expansion scope
  • Indore hospital in growth phase with 18% top-line growth but flat EBITDA due to medical team investments
  • Company maintains self-imposed debt ceiling of 3x EBITDA
  • Net debt position: INR170+ crores at end of Q2 (INR400+ crores cash, INR600 crores debt)
  • Maintenance capex estimated at INR10-20 crores per unit annually

Forward-Looking Statements: Management indicated that the conference call contained forward-looking statements based on beliefs, opinions, and expectations as of the call date, which are not guarantees of future performance and involve risks and uncertainties.

Additional Notes Section

Attachments: The document references previous intimations dated October 8, 2026 (Intimation of Earnings Conference Call) and October 26, 2026 (Audio Link of Analyst/Investor Conference Call).

Compliance Language: The document is filed pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The transcript includes standard forward-looking statement disclaimer but does not explicitly state that no unpublished price sensitive information (UPSI) was shared.

Financial Data: Substantial financial data was disclosed including quarterly and half-yearly results, operational metrics, and specific project financial details.